Viewing Study NCT06563479



Ignite Creation Date: 2024-10-26 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06563479
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-19

Brief Title: A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
Sponsor: None
Organization: None

Study Overview

Official Title: Phase III Randomized and Double-blinded Trial of De-escalated Radiation in FMISO PET-selected Good Risk Versus Standard of Care Radiation in Unselected HPV Positive Oropharyngeal Cancer
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The researchers are doing this study to find out if a personalized approach to chemoradiation therapy which may include a lower dose of radiation is as effective as the standard chemoradiation therapy in people with HPV-positive throat cancer Other purposes of this study include looking at the following

Whether a lower dose of radiation in combination with standard chemotherapy causes fewer side effects than the standard dose of radiation therapy in combination with standard chemotherapy
How the study approaches lower dose of radiation therapy standard chemotherapy and standard dose of radiation therapy standard chemotherapy affect participants quality of life The researchers will measure quality of life by having participants fill out questionnaires
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None